SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: David Bogdanoff who wrote (2282)9/16/1998 9:43:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 4676
 
Isis Achieves $7.5 Million Milestone for FDA Approval of Antisense CMV Retinitis Drug. European Regulatory Application Undergoing Review. (no market response yet) FYI Scott

biz.yahoo.com



To: David Bogdanoff who wrote (2282)9/22/1998 12:58:00 PM
From: David Bogdanoff  Respond to of 4676
 
To All;

ISIS was favorably mentioned on CNBC this morning because of a recent milestone payment and the possibility of another milestone payment if it receives a European approval for its aids drug. Finally some notice from the media.

David